This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Congenitalheartdisease is a daunting diagnosis for any parent. We’ll cover common types of medications used to treat congenitalheartdisease, what parents should know about their use, and potential side effects to watch out for. Be sure to talk to your doctor if you have any questions or concerns.
Advances in pediatric cardiac surgery have resulted in a recent growing epidemic of children and young adults with congenitalheartdiseases (CHDs). Cardiacfunction significantly influences outcomes in CHDs, necessitating regular patient follow-up to detect clinical changes and relevant risk factors.
Background:There are limited data about changes in cardiacfunction (cardiac reverse remodeling) and heart failure indices after transcatheter tricuspid valve-in-valve replacement (TT-VIVR). Circulation: Cardiovascular Interventions, Ahead of Print.
Background Hypoplastic left heart syndrome (HLHS) accounts for 2.6% of congenitalheartdisease and is an invariably fatal cardiac anomaly if left untreated. Notably, all surviving patients maintained preserved and satisfactory cardiacfunction with good clinical status.
An improved understanding of heart development could help inform new clinical strategies in managing congenitalheartdiseases, which are the most common type of birth defects, said research team leader Shang Wang from Stevens Institute of Technology.
Background:Without timely intervention, pressure-overloading left ventricular (poLV) remodeling may become progressive and readily degenerate into heart failure. Plasma Kyn levels were clinically associated with the cardiacfunctions and the degree of remodeling.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content